Letter: Switching to tenofovir alafenamide for nucleos(t)ide analogue-experienced patients with chronic hepatitis B can increase body weight-Authors' reply

Aliment Pharmacol Ther. 2024 Apr;59(7):909-910. doi: 10.1111/apt.17910.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adenine / therapeutic use
  • Antiviral Agents / therapeutic use
  • Hepatitis B e Antigens
  • Hepatitis B virus
  • Hepatitis B, Chronic* / drug therapy
  • Humans
  • Tenofovir / therapeutic use
  • Treatment Outcome

Substances

  • Antiviral Agents
  • Tenofovir
  • Adenine
  • Hepatitis B e Antigens